Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27844106)

  • 1. Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.
    England CG; Rui L; Cai W
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):517-532. PubMed ID: 27844106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of molecular imaging and radioimmunotherapy in lymphoma.
    Iagaru A; Goris ML; Gambhir SS
    Radiol Clin North Am; 2008 Mar; 46(2):243-52, viii. PubMed ID: 18619379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nuclear medicine and lymphoma].
    Fernández de Sevilla Ribosa A
    Rev Esp Med Nucl; 2006; 25(2):77-9. PubMed ID: 16759612
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma.
    Ria R; Musto P; Reale A; Guariglia R; Iodice G; Dammacco F; Vacca A
    J Nucl Med; 2011 Jun; 52(6):891-5. PubMed ID: 21571787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of immunoPET in receptor targeted cancer therapy.
    Marik J; Junutula JR
    Curr Drug Deliv; 2011 Jan; 8(1):70-8. PubMed ID: 21034420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma.
    O'Donnell RT; Leigh BR; Christensen SD; Goldstein DS; Kukis DL; Shen S; Yuan A; DeNardo DA; Kroger LA; DeNardo GL
    Cancer Biother Radiopharm; 1999 Jun; 14(3):167-76. PubMed ID: 10850301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.
    Knowles SM; Wu AM
    J Clin Oncol; 2012 Nov; 30(31):3884-92. PubMed ID: 22987087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of immuno-PET in radioimmunotherapy.
    Verel I; Visser GW; van Dongen GA
    J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
    Bodet-Milin C; Kraeber-Bodéré F; Dupas B; Morschhauser F; Gastinne T; Le Gouill S; Campion L; Harousseau JL; Wegener WA; Goldenberg DM; Huglo D
    Haematologica; 2008 Mar; 93(3):390-7. PubMed ID: 18268287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibody treatment of malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of incurable lymphoma.
    DeNardo GL; Sysko VV; DeNardo SJ
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S46-56. PubMed ID: 16979440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy for non-Hodgkin's lymphoma.
    Liebenguth P; Vogt Temple S
    Semin Oncol Nurs; 2006 Nov; 22(4):257-66. PubMed ID: 17095402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective.
    Wang Q; Zhang X; Wei W; Cao M
    Mol Pharm; 2022 Oct; 19(10):3471-3483. PubMed ID: 35771950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the mechanisms of action of radioimmunotherapy in lymphoma.
    Ivanov A; Swann R; Illidge T
    J Pharm Pharmacol; 2008 Aug; 60(8):987-98. PubMed ID: 18644192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of novel strategies to enhance monoclonal antibodies targeting.
    Khawli LA; Epstein AL
    Q J Nucl Med; 1997 Mar; 41(1):25-35. PubMed ID: 9195850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.